Diprivan and Ms contin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diprivan (propofol) and Ms contin (morphine sulfate). Common drug interactions include atelectasis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Diprivan and Ms contin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.



On Jul, 07, 2026

21 people who take Diprivan and Ms contin together, and have interactions are studied.

Diprivan and Ms contin drug interactions.

What are the common drug interactions of Diprivan and Ms Contin, by gender? *:

female:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Bone disorder
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cardiac arrest
  6. Cardiac failure congestive
  7. Cardiomegaly (increased size of heart than normal)
  8. Cardiovascular disorder (heart diseases)
  9. Cellulitis (infection under the skin)
  10. Coagulopathy (blood's ability to clot is impaired)

male:

  1. Arthralgia (joint pain)
  2. Injury
  3. Aortic dilatation
  4. Arrhythmia (irregular heartbeat)
  5. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  6. Arteriovenous fistula site complication
  7. Atelectasis (partial or complete collapse of the lung)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Bone disorder
  10. Bone pain

What are the common drug interactions of Diprivan and Ms Contin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dysgeusia (disorder of the sense of taste)
  2. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  3. Erythema multiforme (a type of hypersensitivity reaction)
  4. Flushing (the warm, red condition of human skin)
  5. Injection site reaction
  6. Interstitial lung disease
  7. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Streptococcal infection

50-59:

  1. Cardiac disorder
  2. Cardiac failure congestive
  3. Cardiomegaly (increased size of heart than normal)
  4. Cardiovascular disorder (heart diseases)
  5. Cellulitis (infection under the skin)
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Deafness
  9. Decreased appetite
  10. Dilatation ventricular

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abscess neck (neck abscesses)
  3. Arteriovenous fistula site complication
  4. Arthralgia (joint pain)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Bone disorder
  8. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
  9. Breast haematoma (blood-filled swelling in the breast)
  10. Cardiac arrest

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 11 people, 52.38%
  2. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 11 people, 52.38%
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood): 6 people, 28.57%
  4. Nausea (feeling of having an urge to vomit): 2 people, 9.52%
  5. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 9.52%
  6. Infectious Pleural Effusion (infectious fluid in the lung): 2 people, 9.52%
  7. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 9.52%
  8. Hyperglycemia (high blood sugar): 2 people, 9.52%
  9. High Blood Pressure: 2 people, 9.52%
  10. Empyema (collection of pus in a cavity in the body): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and Ms contin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diprivan and Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diprivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on propofol and morphine sulfate (the active ingredients of Diprivan and Ms contin, respectively), and Diprivan and Ms contin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: